//
Clinical epidemiology of heart failure with preserved ejection fraction (HFpEF) in comparatively young hospitalized patients
Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes
The Management of Atrial Fibrillation in Heart Failure: An Expert Panel Consensus
Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"
Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction
Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist Systems
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial
Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators